New paper in Nutrition Research

L-Carnosine effective in MS

Our recent study published in Nutrition Research describes the effects of L-carnosine administration on various patient- and clinician-reported outcomes in a case series of patients with multiple sclerosis (MS). L-carnosine was administered orally for 8 weeks in two women and one man suffering from MS. The intensity of symptoms and signs of MS diminished in various domains, and MRS spectroscopy revealed increased brain choline-contained compounds, total creatine, and myo-inositol levels in girus cinguli at 8-week follow-up in all MS cases. This case study demonstrates that 8-week intervention with L-carnosine appears to be a safe and beneficial therapeutic strategy with regard to the reduction of presence and severity of symptoms of MS. More ABL studies in this domain are coming soon!

Share this post